Aua Capital Management, LLC Bristol Myers Squibb CO Transaction History

Aua Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$57.89 - $64.73 $43,128 - $48,223	745 Added 23.34%	3,937 $228,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $96 - $57,245	-745 Reduced 18.92%	3,192 $227,000
Q2 2020 Jul 13, 2020	SELL	$54.82 - $64.09 $21,050 - $24,610	-384 Reduced 8.89%	3,937 $231,000
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $92,711 - $120,933	1,884 Added 77.31%	4,321 $277,000
Q3 2017 Oct 20, 2017	BUY	$55.23 - $63.74 $134,595 - $155,334	2,437	2,437 $156,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Aua Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aua Capital Management, LLC with notifications on news.